XWELL’s $31.3 Million Private Placement Targets Balance Sheet Reboot and Growth Flexibility
Market Chameleon (Thu, 26-Feb 5:39 AM ET)
XWELL Secures $31.3 Million Private Placement—Warrants Priced for Immediate Upside
Market Chameleon (Wed, 25-Feb 4:51 AM ET)
AI Biotech, APAC Expansion, and Balance Sheet Rebuilds Set the Morning Tone
Globe Newswire (Wed, 25-Feb 9:38 AM ET)
Globe Newswire (Tue, 24-Feb 4:15 PM ET)
XWELL and PieQ Advance AI-Powered Biosecurity Forecasting Following CDC Milestone
Globe Newswire (Tue, 3-Feb 8:00 AM ET)
XWELL Reaffirms Commitment to Biosecurity, Appoints Former CDC Senior Advisor
Globe Newswire (Thu, 8-Jan 8:00 AM ET)
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers with premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.
Xwell trades on the NASDAQ stock market under the symbol XWEL.
As of March 27, 2026, XWEL stock price declined to $1.20 with 176,989 million shares trading.
XWEL has a beta of 0.22, meaning it tends to be less sensitive to market movements. XWEL has a correlation of 0.00 to the broad based SPY ETF.
XWEL has a market cap of $6.92 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, XWEL traded as high as $7.55 and as low as $.26.
The top ETF exchange traded funds that XWEL belongs to (by Net Assets): VXF.
XWEL has underperformed the market in the last year with a price return of +0.8% while the SPY ETF gained +13.1%. However, in the short term, XWEL had mixed performance relative to the market. It has outperformed in the last 3 months, returning +94.2% vs -7.9% return in SPY. But in the last 2 weeks, XWEL shares have been beat by the market, returning -24.1% compared to an SPY return of -4.0%.
XWEL support price is $1.16 and resistance is $1.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XWEL shares will trade within this expected range on the day.
